Two drugs targeting ‘zombie cells’ show promise for treating chronic back pain
In a preclinical study led by McGill University researchers, two drugs targeting "zombie cells" have…
In a preclinical study led by McGill University researchers, two drugs targeting "zombie cells" have…
Scientists at .Neurorestore (EPFL/CHUV/UNIL)* have developed an approach that combines rehabilitation robotics with spinal cord…
A new systematic review, examining 90 studies conducted over a 16-year period, has been developed…
University of Wisconsin-Madison researchers, building on their previous work on mRNA-based vaccines, have developed a…
A research team from the Korean university, POSTECH, have demonstrated a ground-breaking technique for bone…
Once again, BackCare fielded a full team of runners for the 2024 London Marathon, raising…
After lengthy technical difficulties, we are pleased to announce that HOP7 is now available for…
Back Care Awareness Week 2023, starting from the 2nd October, is focused on back pain…
Our Distribution hub have confirmed that our eagerly awaited 7th edition of the Handling of…
BackCare would like to thank our 2023 London Marathon runners and their supporters for their…